Expanding Service Offerings Spherix Global Insights recently launched a new suite of services focused on Market Access, providing opportunities to cross-sell by demonstrating expertise in payer strategy, customer engagement, and patient services within biopharma companies seeking comprehensive market solutions.

Focused Therapeutic Expertise With specialized market knowledge across seven therapeutic areas including Oncology, dermatology, and nephrology, Spherix can tailor solutions to pharmaceutical organizations targeting these high-growth sectors, facilitating targeted outreach and product positioning strategies.

Recent Market Intelligence The company's latest reports on PD-1 inhibition and biologic switching indicate deep insights into oncology and autoimmune therapies, presenting sales opportunities to engage biopharma firms looking for competitive intelligence and trends analysis in these areas.

Growing Industry Presence With a revenue range of 25 to 50 million dollars and a strategic focus on expanding advisory services, Spherix offers partnership and consultancy prospects for vendors and technology providers seeking to embed innovative solutions within the life sciences market research space.

Strong Thought Leadership Their commitment to publishing detailed patient chart analyses and launching new annual reports signifies a reputable presence in the market research sector, which can be leveraged to build credibility with clients interested in clinical insights, patient engagement, and market trends.